Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Veterinary/Animal Vaccines Market Growth 2022-2028

  • LP 4719602
  • 108 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Veterinary/Animal Vaccines will have significant change from previous year. According to our (LP Information) latest study, the global Veterinary/Animal Vaccines market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Veterinary/Animal Vaccines market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Veterinary/Animal Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Veterinary/Animal Vaccines market, reaching US$ million by the year 2028. As for the Europe Veterinary/Animal Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Veterinary/Animal Vaccines players cover Zoetis, Merck Animal Health, Boehringer Ingelheim, and Elanco, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary/Animal Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Live Attenuated Vaccines

Inactivated Vaccines

Toxoid Vaccines

Recombinant Vaccines

Other Vaccines

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospitals and Clinics

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Zoetis

Merck Animal Health

Boehringer Ingelheim

Elanco

Virbac

Vetoquinol

Phibro Animal Health

Hester

Hipra

Idt Biologika

Biogenesis Bago

Tianjin Ringpu

China Animal Husbandry

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Veterinary/Animal Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Veterinary/Animal Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Veterinary/Animal Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Veterinary/Animal Vaccines Segment by Type

2.2.1 Live Attenuated Vaccines

2.2.2 Inactivated Vaccines

2.2.3 Toxoid Vaccines

2.2.4 Recombinant Vaccines

2.2.5 Other Vaccines

2.3 Veterinary/Animal Vaccines Sales by Type

2.3.1 Global Veterinary/Animal Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Veterinary/Animal Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Veterinary/Animal Vaccines Sale Price by Type (2017-2022)

2.4 Veterinary/Animal Vaccines Segment by Application

2.4.1 Hospitals and Clinics

2.4.2 Others

2.5 Veterinary/Animal Vaccines Sales by Application

2.5.1 Global Veterinary/Animal Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Veterinary/Animal Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Veterinary/Animal Vaccines Sale Price by Application (2017-2022)

3 Global Veterinary/Animal Vaccines by Company

3.1 Global Veterinary/Animal Vaccines Breakdown Data by Company

3.1.1 Global Veterinary/Animal Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Veterinary/Animal Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Veterinary/Animal Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Veterinary/Animal Vaccines Revenue by Company (2020-2022)

3.2.2 Global Veterinary/Animal Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Veterinary/Animal Vaccines Sale Price by Company

3.4 Key Manufacturers Veterinary/Animal Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Veterinary/Animal Vaccines Product Location Distribution

3.4.2 Players Veterinary/Animal Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Veterinary/Animal Vaccines by Geographic Region

4.1 World Historic Veterinary/Animal Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Veterinary/Animal Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Veterinary/Animal Vaccines Annual Revenue by Geographic Region

4.2 World Historic Veterinary/Animal Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Veterinary/Animal Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Veterinary/Animal Vaccines Annual Revenue by Country/Region

4.3 Americas Veterinary/Animal Vaccines Sales Growth

4.4 APAC Veterinary/Animal Vaccines Sales Growth

4.5 Europe Veterinary/Animal Vaccines Sales Growth

4.6 Middle East & Africa Veterinary/Animal Vaccines Sales Growth

5 Americas

5.1 Americas Veterinary/Animal Vaccines Sales by Country

5.1.1 Americas Veterinary/Animal Vaccines Sales by Country (2017-2022)

5.1.2 Americas Veterinary/Animal Vaccines Revenue by Country (2017-2022)

5.2 Americas Veterinary/Animal Vaccines Sales by Type

5.3 Americas Veterinary/Animal Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Veterinary/Animal Vaccines Sales by Region

6.1.1 APAC Veterinary/Animal Vaccines Sales by Region (2017-2022)

6.1.2 APAC Veterinary/Animal Vaccines Revenue by Region (2017-2022)

6.2 APAC Veterinary/Animal Vaccines Sales by Type

6.3 APAC Veterinary/Animal Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Veterinary/Animal Vaccines by Country

7.1.1 Europe Veterinary/Animal Vaccines Sales by Country (2017-2022)

7.1.2 Europe Veterinary/Animal Vaccines Revenue by Country (2017-2022)

7.2 Europe Veterinary/Animal Vaccines Sales by Type

7.3 Europe Veterinary/Animal Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Veterinary/Animal Vaccines by Country

8.1.1 Middle East & Africa Veterinary/Animal Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Veterinary/Animal Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Veterinary/Animal Vaccines Sales by Type

8.3 Middle East & Africa Veterinary/Animal Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Veterinary/Animal Vaccines

10.3 Manufacturing Process Analysis of Veterinary/Animal Vaccines

10.4 Industry Chain Structure of Veterinary/Animal Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Veterinary/Animal Vaccines Distributors

11.3 Veterinary/Animal Vaccines Customer

12 World Forecast Review for Veterinary/Animal Vaccines by Geographic Region

12.1 Global Veterinary/Animal Vaccines Market Size Forecast by Region

12.1.1 Global Veterinary/Animal Vaccines Forecast by Region (2023-2028)

12.1.2 Global Veterinary/Animal Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Veterinary/Animal Vaccines Forecast by Type

12.7 Global Veterinary/Animal Vaccines Forecast by Application

13 Key Players Analysis

13.1 Zoetis

13.1.1 Zoetis Company Information

13.1.2 Zoetis Veterinary/Animal Vaccines Product Offered

13.1.3 Zoetis Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Zoetis Main Business Overview

13.1.5 Zoetis Latest Developments

13.2 Merck Animal Health

13.2.1 Merck Animal Health Company Information

13.2.2 Merck Animal Health Veterinary/Animal Vaccines Product Offered

13.2.3 Merck Animal Health Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Animal Health Main Business Overview

13.2.5 Merck Animal Health Latest Developments

13.3 Boehringer Ingelheim

13.3.1 Boehringer Ingelheim Company Information

13.3.2 Boehringer Ingelheim Veterinary/Animal Vaccines Product Offered

13.3.3 Boehringer Ingelheim Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Boehringer Ingelheim Main Business Overview

13.3.5 Boehringer Ingelheim Latest Developments

13.4 Elanco

13.4.1 Elanco Company Information

13.4.2 Elanco Veterinary/Animal Vaccines Product Offered

13.4.3 Elanco Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Elanco Main Business Overview

13.4.5 Elanco Latest Developments

13.5 Virbac

13.5.1 Virbac Company Information

13.5.2 Virbac Veterinary/Animal Vaccines Product Offered

13.5.3 Virbac Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Virbac Main Business Overview

13.5.5 Virbac Latest Developments

13.6 Vetoquinol

13.6.1 Vetoquinol Company Information

13.6.2 Vetoquinol Veterinary/Animal Vaccines Product Offered

13.6.3 Vetoquinol Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Vetoquinol Main Business Overview

13.6.5 Vetoquinol Latest Developments

13.7 Phibro Animal Health

13.7.1 Phibro Animal Health Company Information

13.7.2 Phibro Animal Health Veterinary/Animal Vaccines Product Offered

13.7.3 Phibro Animal Health Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Phibro Animal Health Main Business Overview

13.7.5 Phibro Animal Health Latest Developments

13.8 Hester

13.8.1 Hester Company Information

13.8.2 Hester Veterinary/Animal Vaccines Product Offered

13.8.3 Hester Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Hester Main Business Overview

13.8.5 Hester Latest Developments

13.9 Hipra

13.9.1 Hipra Company Information

13.9.2 Hipra Veterinary/Animal Vaccines Product Offered

13.9.3 Hipra Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Hipra Main Business Overview

13.9.5 Hipra Latest Developments

13.10 Idt Biologika

13.10.1 Idt Biologika Company Information

13.10.2 Idt Biologika Veterinary/Animal Vaccines Product Offered

13.10.3 Idt Biologika Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Idt Biologika Main Business Overview

13.10.5 Idt Biologika Latest Developments

13.11 Biogenesis Bago

13.11.1 Biogenesis Bago Company Information

13.11.2 Biogenesis Bago Veterinary/Animal Vaccines Product Offered

13.11.3 Biogenesis Bago Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Biogenesis Bago Main Business Overview

13.11.5 Biogenesis Bago Latest Developments

13.12 Tianjin Ringpu

13.12.1 Tianjin Ringpu Company Information

13.12.2 Tianjin Ringpu Veterinary/Animal Vaccines Product Offered

13.12.3 Tianjin Ringpu Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Tianjin Ringpu Main Business Overview

13.12.5 Tianjin Ringpu Latest Developments

13.13 China Animal Husbandry

13.13.1 China Animal Husbandry Company Information

13.13.2 China Animal Husbandry Veterinary/Animal Vaccines Product Offered

13.13.3 China Animal Husbandry Veterinary/Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 China Animal Husbandry Main Business Overview

13.13.5 China Animal Husbandry Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Veterinary/Animal Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Veterinary/Animal Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Live Attenuated Vaccines

Table 4. Major Players of Inactivated Vaccines

Table 5. Major Players of Toxoid Vaccines

Table 6. Major Players of Recombinant Vaccines

Table 7. Major Players of Other Vaccines

Table 8. Global Veterinary/Animal Vaccines Sales by Type (2017-2022) & (K Units)

Table 9. Global Veterinary/Animal Vaccines Sales Market Share by Type (2017-2022)

Table 10. Global Veterinary/Animal Vaccines Revenue by Type (2017-2022) & ($ million)

Table 11. Global Veterinary/Animal Vaccines Revenue Market Share by Type (2017-2022)

Table 12. Global Veterinary/Animal Vaccines Sale Price by Type (2017-2022) & (USD/Unit)

Table 13. Global Veterinary/Animal Vaccines Sales by Application (2017-2022) & (K Units)

Table 14. Global Veterinary/Animal Vaccines Sales Market Share by Application (2017-2022)

Table 15. Global Veterinary/Animal Vaccines Revenue by Application (2017-2022)

Table 16. Global Veterinary/Animal Vaccines Revenue Market Share by Application (2017-2022)

Table 17. Global Veterinary/Animal Vaccines Sale Price by Application (2017-2022) & (USD/Unit)

Table 18. Global Veterinary/Animal Vaccines Sales by Company (2020-2022) & (K Units)

Table 19. Global Veterinary/Animal Vaccines Sales Market Share by Company (2020-2022)

Table 20. Global Veterinary/Animal Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Veterinary/Animal Vaccines Revenue Market Share by Company (2020-2022)

Table 22. Global Veterinary/Animal Vaccines Sale Price by Company (2020-2022) & (USD/Unit)

Table 23. Key Manufacturers Veterinary/Animal Vaccines Producing Area Distribution and Sales Area

Table 24. Players Veterinary/Animal Vaccines Products Offered

Table 25. Veterinary/Animal Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Veterinary/Animal Vaccines Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Veterinary/Animal Vaccines Sales Market Share Geographic Region (2017-2022)

Table 30. Global Veterinary/Animal Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Veterinary/Animal Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Veterinary/Animal Vaccines Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Veterinary/Animal Vaccines Sales Market Share by Country/Region (2017-2022)

Table 34. Global Veterinary/Animal Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Veterinary/Animal Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Veterinary/Animal Vaccines Sales by Country (2017-2022) & (K Units)

Table 37. Americas Veterinary/Animal Vaccines Sales Market Share by Country (2017-2022)

Table 38. Americas Veterinary/Animal Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Veterinary/Animal Vaccines Revenue Market Share by Country (2017-2022)

Table 40. Americas Veterinary/Animal Vaccines Sales by Type (2017-2022) & (K Units)

Table 41. Americas Veterinary/Animal Vaccines Sales Market Share by Type (2017-2022)

Table 42. Americas Veterinary/Animal Vaccines Sales by Application (2017-2022) & (K Units)

Table 43. Americas Veterinary/Animal Vaccines Sales Market Share by Application (2017-2022)

Table 44. APAC Veterinary/Animal Vaccines Sales by Region (2017-2022) & (K Units)

Table 45. APAC Veterinary/Animal Vaccines Sales Market Share by Region (2017-2022)

Table 46. APAC Veterinary/Animal Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Veterinary/Animal Vaccines Revenue Market Share by Region (2017-2022)

Table 48. APAC Veterinary/Animal Vaccines Sales by Type (2017-2022) & (K Units)

Table 49. APAC Veterinary/Animal Vaccines Sales Market Share by Type (2017-2022)

Table 50. APAC Veterinary/Animal Vaccines Sales by Application (2017-2022) & (K Units)

Table 51. APAC Veterinary/Animal Vaccines Sales Market Share by Application (2017-2022)

Table 52. Europe Veterinary/Animal Vaccines Sales by Country (2017-2022) & (K Units)

Table 53. Europe Veterinary/Animal Vaccines Sales Market Share by Country (2017-2022)

Table 54. Europe Veterinary/Animal Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Veterinary/Animal Vaccines Revenue Market Share by Country (2017-2022)

Table 56. Europe Veterinary/Animal Vaccines Sales by Type (2017-2022) & (K Units)

Table 57. Europe Veterinary/Animal Vaccines Sales Market Share by Type (2017-2022)

Table 58. Europe Veterinary/Animal Vaccines Sales by Application (2017-2022) & (K Units)

Table 59. Europe Veterinary/Animal Vaccines Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Veterinary/Animal Vaccines Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Veterinary/Animal Vaccines Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Veterinary/Animal Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Veterinary/Animal Vaccines Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Veterinary/Animal Vaccines Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Veterinary/Animal Vaccines Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Veterinary/Animal Vaccines Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Veterinary/Animal Vaccines Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Veterinary/Animal Vaccines

Table 69. Key Market Challenges & Risks of Veterinary/Animal Vaccines

Table 70. Key Industry Trends of Veterinary/Animal Vaccines

Table 71. Veterinary/Animal Vaccines Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Veterinary/Animal Vaccines Distributors List

Table 74. Veterinary/Animal Vaccines Customer List

Table 75. Global Veterinary/Animal Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Veterinary/Animal Vaccines Sales Market Forecast by Region

Table 77. Global Veterinary/Animal Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Veterinary/Animal Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Veterinary/Animal Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Veterinary/Animal Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Veterinary/Animal Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Veterinary/Animal Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Veterinary/Animal Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Veterinary/Animal Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Veterinary/Animal Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Veterinary/Animal Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Veterinary/Animal Vaccines Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Veterinary/Animal Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Veterinary/Animal Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Veterinary/Animal Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Veterinary/Animal Vaccines Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Veterinary/Animal Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Veterinary/Animal Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Veterinary/Animal Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 95. Zoetis Basic Information, Veterinary/Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 96. Zoetis Veterinary/Animal Vaccines Product Offered

Table 97. Zoetis Veterinary/Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 98. Zoetis Main Business

Table 99. Zoetis Latest Developments

Table 100. Merck Animal Health Basic Information, Veterinary/Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 101. Merck Animal Health Veterinary/Animal Vaccines Product Offered

Table 102. Merck Animal Health Veterinary/Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 103. Merck Animal Health Main Business

Table 104. Merck Animal Health Latest Developments

Table 105. Boehringer Ingelheim Basic Information, Veterinary/Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 106. Boehringer Ingelheim Veterinary/Animal Vaccines Product Offered

Table 107. Boehringer Ingelheim Veterinary/Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 108. Boehringer Ingelheim Main Business

Table 109. Boehringer Ingelheim Latest Developments

Table 110. Elanco Basic Information, Veterinary/Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 111. Elanco Veterinary/Animal Vaccines Product Offered

Table 112. Elanco Veterinary/Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 113. Elanco Main Business

Table 114. Elanco Latest Developments

Table 115. Virbac Basic Information, Veterinary/Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 116. Virbac Veterinary/Animal Vaccines Product Offered

Table 117. Virbac Veterinary/Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 118. Virbac Main Business

Table 119. Virbac Latest Developments

Table 120. Vetoquinol Basic Information, Veterinary/Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 121. Vetoquinol Veterinary/Animal Vaccines Product Offered

Table 122. Vetoquinol Veterinary/Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 123. Vetoquinol Main Business

Table 124. Vetoquinol Latest Developments

Table 125. Phibro Animal Health Basic Information, Veterinary/Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 126. Phibro Animal Health Veterinary/Animal Vaccines Product Offered

Table 127. Phibro Animal Health Veterinary/Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 128. Phibro Animal Health Main Business

Table 129. Phibro Animal Health Latest Developments

Table 130. Hester Basic Information, Veterinary/Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 131. Hester Veterinary/Animal Vaccines Product Offered

Table 132. Hester Veterinary/Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 133. Hester Main Business

Table 134. Hester Latest Developments

Table 135. Hipra Basic Information, Veterinary/Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 136. Hipra Veterinary/Animal Vaccines Product Offered

Table 137. Hipra Veterinary/Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 138. Hipra Main Business

Table 139. Hipra Latest Developments

Table 140. Idt Biologika Basic Information, Veterinary/Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 141. Idt Biologika Veterinary/Animal Vaccines Product Offered

Table 142. Idt Biologika Veterinary/Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 143. Idt Biologika Main Business

Table 144. Idt Biologika Latest Developments

Table 145. Biogenesis Bago Basic Information, Veterinary/Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 146. Biogenesis Bago Veterinary/Animal Vaccines Product Offered

Table 147. Biogenesis Bago Veterinary/Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 148. Biogenesis Bago Main Business

Table 149. Biogenesis Bago Latest Developments

Table 150. Tianjin Ringpu Basic Information, Veterinary/Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 151. Tianjin Ringpu Veterinary/Animal Vaccines Product Offered

Table 152. Tianjin Ringpu Veterinary/Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 153. Tianjin Ringpu Main Business

Table 154. Tianjin Ringpu Latest Developments

Table 155. China Animal Husbandry Basic Information, Veterinary/Animal Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 156. China Animal Husbandry Veterinary/Animal Vaccines Product Offered

Table 157. China Animal Husbandry Veterinary/Animal Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 158. China Animal Husbandry Main Business

Table 159. China Animal Husbandry Latest Developments

List of Figures

Figure 1. Picture of Veterinary/Animal Vaccines

Figure 2. Veterinary/Animal Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Veterinary/Animal Vaccines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Veterinary/Animal Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Veterinary/Animal Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Live Attenuated Vaccines

Figure 10. Product Picture of Inactivated Vaccines

Figure 11. Product Picture of Toxoid Vaccines

Figure 12. Product Picture of Recombinant Vaccines

Figure 13. Product Picture of Other Vaccines

Figure 14. Global Veterinary/Animal Vaccines Sales Market Share by Type in 2021

Figure 15. Global Veterinary/Animal Vaccines Revenue Market Share by Type (2017-2022)

Figure 16. Veterinary/Animal Vaccines Consumed in Hospitals and Clinics

Figure 17. Global Veterinary/Animal Vaccines Market: Hospitals and Clinics (2017-2022) & (K Units)

Figure 18. Veterinary/Animal Vaccines Consumed in Others

Figure 19. Global Veterinary/Animal Vaccines Market: Others (2017-2022) & (K Units)

Figure 20. Global Veterinary/Animal Vaccines Sales Market Share by Application (2017-2022)

Figure 21. Global Veterinary/Animal Vaccines Revenue Market Share by Application in 2021

Figure 22. Veterinary/Animal Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Veterinary/Animal Vaccines Revenue Market Share by Company in 2021

Figure 24. Global Veterinary/Animal Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Veterinary/Animal Vaccines Revenue Market Share by Geographic Region in 2021

Figure 26. Global Veterinary/Animal Vaccines Sales Market Share by Region (2017-2022)

Figure 27. Global Veterinary/Animal Vaccines Revenue Market Share by Country/Region in 2021

Figure 28. Americas Veterinary/Animal Vaccines Sales 2017-2022 (K Units)

Figure 29. Americas Veterinary/Animal Vaccines Revenue 2017-2022 ($ Millions)

Figure 30. APAC Veterinary/Animal Vaccines Sales 2017-2022 (K Units)

Figure 31. APAC Veterinary/Animal Vaccines Revenue 2017-2022 ($ Millions)

Figure 32. Europe Veterinary/Animal Vaccines Sales 2017-2022 (K Units)

Figure 33. Europe Veterinary/Animal Vaccines Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Veterinary/Animal Vaccines Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Veterinary/Animal Vaccines Revenue 2017-2022 ($ Millions)

Figure 36. Americas Veterinary/Animal Vaccines Sales Market Share by Country in 2021

Figure 37. Americas Veterinary/Animal Vaccines Revenue Market Share by Country in 2021

Figure 38. United States Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Veterinary/Animal Vaccines Sales Market Share by Region in 2021

Figure 43. APAC Veterinary/Animal Vaccines Revenue Market Share by Regions in 2021

Figure 44. China Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Veterinary/Animal Vaccines Sales Market Share by Country in 2021

Figure 51. Europe Veterinary/Animal Vaccines Revenue Market Share by Country in 2021

Figure 52. Germany Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Veterinary/Animal Vaccines Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Veterinary/Animal Vaccines Revenue Market Share by Country in 2021

Figure 59. Egypt Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Veterinary/Animal Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Veterinary/Animal Vaccines in 2021

Figure 65. Manufacturing Process Analysis of Veterinary/Animal Vaccines

Figure 66. Industry Chain Structure of Veterinary/Animal Vaccines

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390